NVI-100 is a first-in-class water-soluble peptide antagonist for the calcitonin gene-related peptide (CGRP) receptor delivered via a patient-friendly autoinjector for the acute treatment of migraine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback